Usa India city Delhi city Hyderabad covid-19 vaccine infection Usa India city Delhi city Hyderabad

Aurobindo Pharma to make COVAXX's potential COVID-19 vaccine for India, UNICEF

Reading now: 872
www.livemint.com

Aurobindo Pharma Ltd said on Thursday it would make and sell U.S.-based COVAXX's COVID-19 vaccine candidate for supply in India and to the United Nations Children's Fund (UNICEF) under a licensing deal.The Indian drugmaker also has non-exclusive rights to sell the shot — which is currently undergoing an early-stage trial — in certain other emerging markets, the Hyderabad-based company said in an exchange filing.Also Read | Inside the farmer disquiet at Delhi’s doorstepCOVAXX, a unit of privately-owned United Biomedical Inc, plans to pursue mid- and late-stage trials for the vaccine candidate from early 2021 in Asia, Latin America and the United States.The companies said the shot uses normal refrigeration as opposed to the freezing.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA